Loading stock data…
Loading stock data…
US$0.64
Get one email when CPMV crosses your level. Checked every 15 minutes during market hours.
▲ +0.02 (3.23%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
45.5
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.01
Bearish momentumMACD below its signal line (0.00).
50-day average
0.65
Price belowShort-term trend reference.
200-day average
0.61
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Mosaic ImmunoEngineering Inc. is a biotechnology company focused on developing innovative immunotherapies for cancer treatment. The primary purpose of Mosaic ImmunoEngineering is to harness engineered virus-like particles to stimulate the body's immune response against cancer cells. One of the notable features of the company is its approach to using plant viruses, specifically the Cowpea mosaic virus (CPMV), as a platform for generating robust immune responses. This approach is designed to targe…
www.mosaicie.com| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-18 | — | — | — |
| 2026-04-30 | 2.03 | 2.68 | ✓ Beat |
| 2026-01-07 | 1.94 | 2.13 | ✓ Beat |
| 2025-10-27 | 0.54 | 0.54 | ✓ Beat |
Companies in the same industry, via Finnhub